Medicine
Atgam 250 mg/5 mL injection
Atgam 250 mg/5 mL injection is a prescription medicine containing Equine thymocyte immune globulin for intravenous use, marketed by Pharmacia & Upjohn, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in a refrigerator at 2° to 8°C (36° to 46°F). DO NOT FREEZE. Store in…
Key facts
- Active ingredient (INN)
- Equine thymocyte immune globulin
- Brand
- Atgam
- Strength
- 250 mg/5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 5 ampules of 5 mL
- Marketing authorisation holder
- Pharmacia & Upjohn
- Manufacturer
- Pharmacia & Upjohn
- Origin register
- US FDA, United States
- Storage
- Store in a refrigerator at 2° to 8°C (36° to 46°F). DO NOT FREEZE. Store in the original carton to protect from light. For storage conditions of diluted solution, see Dosage and Administration.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 November 1981
- Identifiers
- RxCUI 197906, 206289DailyMed set ID bd545ba1-2366-4df1-bd67-10dfd7632b54NDC 0009-7224Application BLA103676
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 ampule in 1 carton / 5 mL in 1 ampule | 0009-7224-02 | Pharmacia & Upjohn | 17 November 1981 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Equine thymocyte immune globulin is an immunoglobulin G indicated for renal allograft rejection, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Equine thymocyte immune globulin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Equine thymocyte immune globulinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Atgam prescribing information (Pharmacia & Upjohn) · U.S. National Library of Medicine, DailyMed
Need Atgam 250 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.